TP53 and pancreatic neoplasm: This observation fits perfectly with the generally accepted point of view that the majority of pancreatic tumors show a mutation in TP53—systematically reviewed by [8]—and supports the assumption that the analyzed data set is representative and suitable for making new conclusions.